We are live on ! Find out more
Fairscale Capital

Fairscale Capital Portfolio holdings

AUM $167M Turnover 2.25%
1-Year Est. Return 28.67%
This Fund
S&P 500
This Quarter Est. Return
+18.51%
1 Year Est. Return
+28.67%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$167M
AUM Growth
+$22.8M
Cap. Flow
+$1.04M
Cap. Flow %
0.62%
Top 10 Hldgs %
52.44%
Holding
444
New
7
Increased
24
Reduced
43
Closed
3
Avg Time Held
1.7 years
Top 10 Avg Time Held
1.7 years
Top 20 Avg Time Held
1.7 years

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$222K
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$126K
3
NVDA icon
NVIDIA
NVDA
+$118K
4
FCX icon
Freeport-McMoran
FCX
+$107K
5
SNPS icon
Synopsys
SNPS
+$101K

Sector Composition

Rank Sector Weight
1 Miscellaneous 52.24%
2 Technology 20.89%
3 Financials 6.18%
4 Communication Services 6%
5 Consumer Discretionary 3.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
IHE icon
251
iShares US Pharmaceuticals ETF
IHE
$1.56B
$30K 0.02%
303
– –
2025 Q2
4 quarters
ITA icon
252
iShares US Aerospace & Defense ETF
ITA
$12.1B
$29.8K 0.02%
123
– –
2025 Q2
4 quarters
BUG icon
253
Global X Cybersecurity ETF
BUG
$2.31B
$28.5K 0.02%
747
– –
2024 Q2
8 quarters
SPYG icon
254
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$56.1B
$28.3K 0.02%
238
– –
2024 Q2
8 quarters
NFG icon
255
National Fuel Gas
NFG
$7.61B
$28.3K 0.02%
364
– –
2025 Q4
2 quarters
MAR icon
256
Marriott International
MAR
$103B
$27.4K 0.02%
74
– –
2024 Q2
8 quarters
SILJ icon
257
Amplify Junior Silver Miners ETF
SILJ
$3.18B
$27.3K 0.02%
1,054
– –
2025 Q3
3 quarters
UTHR icon
258
United Therapeutics
UTHR
$25.1B
$27.1K 0.02%
50
– –
2024 Q2
8 quarters
ARKG icon
259
ARK Genomic Revolution ETF
ARKG
$2.19B
$27K 0.02%
642
– –
2024 Q2
8 quarters
RGLD icon
260
Royal Gold
RGLD
$20.5B
$26.9K 0.02%
135
– –
2024 Q2
8 quarters
BHP icon
261
BHP
BHP
$209B
$26.8K 0.02%
322
– –
2025 Q2
4 quarters
SPY icon
262
State Street SPDR S&P 500 ETF Trust
SPY
$819B
$25.5K 0.02%
34
– –
2024 Q2
8 quarters
PSX icon
263
Phillips 66
PSX
$109B
$25.3K 0.02%
150
+1
+0.7% +$172
2024 Q2
8 quarters
USHY icon
264
iShares Broad USD High Yield Corporate Bond ETF
USHY
$26.1B
$25.3K 0.02%
683
– –
2025 Q1
5 quarters
AEP icon
265
American Electric Power
AEP
$69.8B
$25K 0.02%
183
– –
2024 Q2
8 quarters
SPOT icon
266
Spotify
SPOT
$111B
$24.8K 0.01%
54
– –
2024 Q2
8 quarters
BNY icon
267
Bank of New York Mellon
BNY
$100B
$24.6K 0.01%
170
– –
2025 Q2
4 quarters
ROP icon
268
Roper Technologies
ROP
$43.6B
$24K 0.01%
71
– –
2024 Q2
8 quarters
TM icon
269
Toyota
TM
$229B
$23.9K 0.01%
142
– –
2025 Q2
4 quarters
FWONK icon
270
Liberty Media Corporation Series C Common Stock
FWONK
$22.8B
$23.4K 0.01%
246
– –
2025 Q2
4 quarters
LYG icon
271
Lloyds Banking Group
LYG
$78.8B
$23.2K 0.01%
3,976
– –
2025 Q2
4 quarters
EEMV icon
272
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.49B
$23K 0.01%
305
– –
2024 Q2
8 quarters
GBAB icon
273
Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust
GBAB
$347M
$22.9K 0.01%
1,587
– –
2024 Q2
8 quarters
ICE icon
274
Intercontinental Exchange
ICE
$87.6B
$22.8K 0.01%
185
– –
2024 Q2
8 quarters
IYH icon
275
iShares US Healthcare ETF
IYH
$4.5B
$22.7K 0.01%
339
– –
2024 Q2
8 quarters

Similar funds

Fairscale Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Fairscale Capital held 444 positions worth $167M, up 16% from $145M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 2.3%. Fairscale Capital opened 7 new positions and exited 3, leaving the 444-position portfolio largely intact.

By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 51% a quarter earlier, followed by Technology and Financials.

  • Fairscale Capital's largest Q2 2026 buy was Calamos S&P 500 Structured Alt Protection ETF - June: 7,230 shares worth $200K.
  • Fairscale Capital added most to Invesco QQQ Trust in Q2 2026, an estimated $566K increase.
  • Fairscale Capital's biggest Q2 2026 reduction was Amgen, cutting an estimated $222K.
  • Fairscale Capital fully exited Hologic in Q2 2026, selling an estimated $34.2K.
  • Fairscale Capital's ten largest holdings make up 52% of its $167M portfolio in Q2 2026.
  • Fairscale Capital opened 7 new positions and closed 3 in Q2 2026.
  • Fairscale Capital's portfolio value rose 16% quarter-over-quarter to $167M.

Based on Fairscale Capital's 13F filing for Q2 2026, filed 7 Aug 2026.